Literature DB >> 17178221

Amino acid-based enantiomerically pure 3-substituted 1,4-benzodiazepin-2-ones: a new class of anti-ischemic agents.

Jitendra Kumar Mishra1, Puja Garg, Preeti Dohare, Ashutosh Kumar, Mohammad Imran Siddiqi, Madhur Ray, Gautam Panda.   

Abstract

A series of 3-substituted 1,4-benzodiazepin-2-ones derived from S and R amino acids were evaluated for their anti-ischemic activity in vitro. Treatment with compounds 7h, 16, 9d, and 17 decreased the apoptotic neuronal number, however increased the neuronal viability. The compounds decreasing apoptosis could protect neurons from the ischemic injury. The difference in the activities of 1,4-benzodiazepin-2-ones derived from S- and R-amino acids is discussed and explained on the basis of molecular modeling studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17178221     DOI: 10.1016/j.bmcl.2006.12.001

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  (11aS)-7-Bromo-2,3,5,10,11,11a-hexa-hydro-1H-pyrrolo-[2,1-c][1,4]benzodiazepine-3,11-dione.

Authors:  Chao Ma; Zhen-Zhong Wang; Li Pan; Yu Tian; Wei Xiao
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-12-14

2.  Practical and Scalable Manufacturing Process for the Key Intermediate of Poly(ADP-Ribose) Polymerase Inhibitor Olaparib.

Authors:  Zhaohang Chen; Shuai Wang; Kangjie Liu; Rui Zhang; Qiaoying Li; Weiguang Bian; Renzhong Qiao; Chao Li
Journal:  ACS Omega       Date:  2022-02-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.